Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a -72.209% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CCO[C@H]1OC(C(=O)N2CCN(Cc3ccccc3)CC2)=C[C@@H](c2ccccc2)[C@@H]1CCCO
[b] Nc1c(N=Nc2ccccc2F)c(=O)[nH]n1-c1ccccc1
[c] O=C1CCC(C(=O)N2CCN(c3ccccc3Cl)CC2)CN1CC1CCCCC1
[d] O=C(CC1Oc2ccccc2NC1=O)NCc1ccccc1
[e] Cc1cc(C(=O)Nc2ccc(Cl)cc2)c(C)n1Cc1cccs1
Answer: c. O=C1CCC(C(=O)N2CCN(c3ccccc3Cl)CC2)CN1CC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C1CCC(C(=O)N2CCN(c3ccccc3Cl)CC2)CN1CC1CCCCC1
O=C1CCC(C(=O)N2CCN(c3ccccc3Cl)CC2)CN1CC1CCCCC1
5-[4-(2-chlorophenyl)piperazine-1-carbonyl]-1-(cyclohexylmethyl)piperidin-2-one